No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
A Quick Look at Today's Ratings for Cidara Therapeutics(CDTX.US), With a Forecast Between $31 to $47
Cidara Therapeutics Is Maintained at Buy by Guggenheim
JMP Securities Maintains Market Outperform on Cidara Therapeutics, Raises Price Target to $47
Cidara Therapeutics Analyst Ratings
RBC Cuts Price Target on Cidara Therapeutics to $31 From $34, Keeps Outperform, Speculative Risk
Express News | Cidara Therapeutics Inc : Guggenheim Raises Target Price to $35 From $33